These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
594 related articles for article (PubMed ID: 27966519)
1. Combretastatin A4 Regulates Proliferation, Migration, Invasion, and Apoptosis of Thyroid Cancer Cells via PI3K/Akt Signaling Pathway. Liang W; Lai Y; Zhu M; Huang S; Feng W; Gu X Med Sci Monit; 2016 Dec; 22():4911-4917. PubMed ID: 27966519 [TBL] [Abstract][Full Text] [Related]
2. HPIP promotes thyroid cancer cell growth, migration and EMT through activating PI3K/AKT signaling pathway. Wang SC; Chai DS; Chen CB; Wang ZY; Wang L Biomed Pharmacother; 2015 Oct; 75():33-9. PubMed ID: 26463629 [TBL] [Abstract][Full Text] [Related]
3. HPIP promotes epithelial-mesenchymal transition and cisplatin resistance in ovarian cancer cells through PI3K/AKT pathway activation. Bugide S; Gonugunta VK; Penugurti V; Malisetty VL; Vadlamudi RK; Manavathi B Cell Oncol (Dordr); 2017 Apr; 40(2):133-144. PubMed ID: 28039608 [TBL] [Abstract][Full Text] [Related]
4. Berberine could inhibit thyroid carcinoma cells by inducing mitochondrial apoptosis, G0/G1 cell cycle arrest and suppressing migration via PI3K-AKT and MAPK signaling pathways. Li L; Wang X; Sharvan R; Gao J; Qu S Biomed Pharmacother; 2017 Nov; 95():1225-1231. PubMed ID: 28931215 [TBL] [Abstract][Full Text] [Related]
5. Rab22a Promotes Epithelial-Mesenchymal Transition in Papillary Thyroid Carcinoma by Activating PI3K/AKT/mTOR Signaling Pathway. Luo X; Wang J; Lu J; Wang X; Miao Y; Li Q; Li X; Wang L Biomed Res Int; 2022; 2022():1874550. PubMed ID: 35757470 [TBL] [Abstract][Full Text] [Related]
6. Synergistic inhibition of thyroid cancer by suppressing MAPK/PI3K/AKT pathways. Kandil E; Tsumagari K; Ma J; Abd Elmageed ZY; Li X; Slakey D; Mondal D; Abdel-Mageed AB J Surg Res; 2013 Oct; 184(2):898-906. PubMed ID: 23602735 [TBL] [Abstract][Full Text] [Related]
7. Naringin inhibits thyroid cancer cell proliferation and induces cell apoptosis through repressing PI3K/AKT pathway. Zhou J; Xia L; Zhang Y Pathol Res Pract; 2019 Dec; 215(12):152707. PubMed ID: 31727500 [TBL] [Abstract][Full Text] [Related]
8. Metformin inhibits proliferation and migration of endometrial cancer cells through regulating PI3K/AKT/MDM2 pathway. Qiang P; Shao Y; Sun YP; Zhang J; Chen LJ Eur Rev Med Pharmacol Sci; 2019 Feb; 23(4):1778-1785. PubMed ID: 30840303 [TBL] [Abstract][Full Text] [Related]
9. Antiproliferative Activity of Carnosic Acid is Mediated via Inhibition of Cell Migration and Invasion, and Suppression of Phosphatidylinositol 3-Kinases (PI3K)/AKT/Mammalian Target of Rapamycin (mTOR) Signaling Pathway. Zhao L; Zhang J; Fan Y; Li Y Med Sci Monit; 2019 Oct; 25():7864-7871. PubMed ID: 31631173 [TBL] [Abstract][Full Text] [Related]
10. MiR-34a targets GAS1 to promote cell proliferation and inhibit apoptosis in papillary thyroid carcinoma via PI3K/Akt/Bad pathway. Ma Y; Qin H; Cui Y Biochem Biophys Res Commun; 2013 Nov; 441(4):958-63. PubMed ID: 24220341 [TBL] [Abstract][Full Text] [Related]
11. Resveratrol potentiates the anti-tumor effects of rapamycin in papillary thyroid cancer: PI3K/AKT/mTOR pathway involved. Bian P; Hu W; Liu C; Li L Arch Biochem Biophys; 2020 Aug; 689():108461. PubMed ID: 32531316 [TBL] [Abstract][Full Text] [Related]
12. Low expression of PDK1 inhibits renal cell carcinoma cell proliferation, migration, invasion and epithelial mesenchymal transition through inhibition of the PI3K-PDK1-Akt pathway. Zhou WM; Wu GL; Huang J; Li JG; Hao C; He QM; Chen XD; Wang GX; Tu XH Cell Signal; 2019 Apr; 56():1-14. PubMed ID: 30465826 [TBL] [Abstract][Full Text] [Related]
13. Ginsenoside Rh2 impedes proliferation and migration and induces apoptosis by regulating NF-κB, MAPK, and PI3K/Akt/mTOR signaling pathways in osteosarcoma cells. Li C; Gao H; Feng X; Bi C; Zhang J; Yin J J Biochem Mol Toxicol; 2020 Dec; 34(12):e22597. PubMed ID: 32762018 [TBL] [Abstract][Full Text] [Related]
14. Batatasin III Inhibits Migration of Human Lung Cancer Cells by Suppressing Epithelial to Mesenchymal Transition and FAK-AKT Signals. Pinkhien T; Petpiroon N; Sritularak B; Chanvorachote P Anticancer Res; 2017 Nov; 37(11):6281-6289. PubMed ID: 29061811 [TBL] [Abstract][Full Text] [Related]
15. Parthenolide Inhibits the Proliferation of MDA-T32 Papillary Thyroid Carcinoma Cells in Vitro and in Mouse Tumor Xenografts and Activates Autophagy and Apoptosis by Downregulation of the Mammalian Target of Rapamycin (mTOR)/PI3K/AKT Signaling Pathway. Li C; Zhou Y; Cai Y; Shui C; Liu W; Wang X; Jiang J; Zeng D; Gui C; Sun R Med Sci Monit; 2019 Jul; 25():5054-5061. PubMed ID: 31322140 [TBL] [Abstract][Full Text] [Related]
16. N-cadherin promotes thyroid tumorigenesis through modulating major signaling pathways. Da C; Wu K; Yue C; Bai P; Wang R; Wang G; Zhao M; Lv Y; Hou P Oncotarget; 2017 Jan; 8(5):8131-8142. PubMed ID: 28042956 [TBL] [Abstract][Full Text] [Related]
17. 5'-AMP-Activated Protein Kinase Regulates Papillary (TPC-1 and BCPAP) Thyroid Cancer Cell Survival, Migration, Invasion, and Epithelial-to-Mesenchymal Transition. Cazarin JM; Coelho RG; Hecht F; Andrade BM; Carvalho DP Thyroid; 2016 Jul; 26(7):933-42. PubMed ID: 27121619 [TBL] [Abstract][Full Text] [Related]
18. Inhibition of migration and invasion by berberine via inactivation of PI3K/Akt and p38 in human retinoblastoma cell line. Wang Y; Yuan J; Yang L; Wang P; Wang X; Wu Y; Chen K; Ma R; Zhong Y; Guo X; Gong Y; Gui M; Jin Y Adv Clin Exp Med; 2018 Jul; 27(7):899-905. PubMed ID: 29790698 [TBL] [Abstract][Full Text] [Related]
19. Suppressive effects of microRNA-16 on the proliferation, invasion and metastasis of hepatocellular carcinoma cells. Wu WL; Wang WY; Yao WQ; Li GD Int J Mol Med; 2015 Dec; 36(6):1713-9. PubMed ID: 26499886 [TBL] [Abstract][Full Text] [Related]
20. Irisin suppresses the migration, proliferation, and invasion of lung cancer cells via inhibition of epithelial-to-mesenchymal transition. Shao L; Li H; Chen J; Song H; Zhang Y; Wu F; Wang W; Zhang W; Wang F; Li H; Tang D Biochem Biophys Res Commun; 2017 Apr; 485(3):598-605. PubMed ID: 27986567 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]